Exosomes from tumor cells package assorted proteins and chemokines with immunomodulatory capability, including CSF-1, CCL2, and TGF-β, to promote M2-like characterization of TAMs (Park et al., 2019). The gene discussed is CSF1; the disease is neoplasm.